Amanote Research

Amanote Research

  • Register
  • Sign In

Eltrombopag for the Treatment of Aplastic Anemia: Current Perspectives

Drug Design, Development and Therapy- New Zealand

doi 10.2147/dddt.s95715

Full Text

Abstract

Available in

Categories

Drug DiscoveryPharmacologyPharmaceutical Science

Date

September 1, 2016

Authors

John GraingerSu Han Lum

Publisher

Informa UK Limited


Related search

Treatment of Aplastic Anemia

Oncologist
Cancer ResearchMedicineOncology
1996English

Current Management of Severe Acquired Aplastic Anemia

Einstein (São Paulo, Brazil)
Medicine
2011English

Iron Mobilization in a Real Life Cohort of Aplastic Anemia Patients Treated With Eltrombopag

American Journal of Hematology
Hematology
2019English

The Thrombopoietin Mimetics Eltrombopag and Romiplostim in the Treatment of Refractory Aplastic Anaemia

British Journal of Haematology
Hematology
2016English

Incidence of Aplastic Anemia in Bangkok. The Aplastic Anemia Study Group

Blood
BiochemistryImmunologyCell BiologyHematology
1991English

Aplastic Anemia

Bone Marrow Transplantation
TransplantationHematology
2002English

Aplastic Anemia in the Elderly: A Nationwide Survey on Behalf of the French Reference Center for Aplastic Anemia.

Haematologica
Hematology
2018English

Cyanamide Induced Aplastic Anemia

Kitakanto Medical Journal
Medicine
2018English

Aplastic Anemia, Pediatric Aspects

Oncologist
Cancer ResearchMedicineOncology
1996English

Amanote Research

Note-taking for researchers

Follow Amanote


© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy